Dexcom (NASDAQ: DXCM), a leader in continuous glucose monitoring for diabetic patients, wished to bring to market a first-ever device that would allow wireless remote monitoring of glucose levels. The idea was to provide peace of mind for users, family members and personal caregivers.

The device was to consist of a small docking cradle in which an existing product, the Dexcom G4 PLATINUM, was docked. The cradle was to be equipped with Bluetooth technology capable of transmitting data from the PLATINUM unit to an app on the patient’s Apple iPhone of iPod touchscreen, allowing as many as five designated individuals access to real-time information through their Apple devices.

Dexcom was unhappy with the original SHARE design, considering it incompatible with the desired brand image of the company’s new G4 product line.

Threatened with falling behind schedule, Dexcom asked MPE (Formerly Mindflow Design) to completely redesign the cradle in just two weeks.

After being hired quickly, MPE (Formerly Mindflow Design) dove right in. We assembled a senior project team to immediately review project and user needs’ data and begin generating product design solutions. Our in-house 3D printing and prototype capabilities proved invaluable as we quickly refined the design through a process that included rapid feedback. Daily communications with the Dexcom team assured that the project stayed on track, on time and on budget. The tasks included Industrial Design and initial CAD file development. We completed the project within the almost impossible two-week deadline.

The Dexcom SHARE, as it became known, came on the market in October 2014 shortly after federal Food and Drug Administration approval. Through customizable glucose alarms and notifications, the follower can help the sharer in time of need. At the time of introduction, the pediatric chief of the famed Joslin Diabetes Center in Boston described the Dexcom SHARE as a “remarkable advance” for its availability as a new communications tool that would help family members and others control diabetes, prevent complications and improve patient quality of life.